Andere talen Zomedica Corp.

Aandelen

ZOM

CA98980M1095

Beurs gesloten - Nyse Andere beurzen 22:00:00 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,142 ^USD	+0,28%		+9,15%	-29,07%

01/04	Zomedica Corp. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
01/04	Zomedica zoekt overnames	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET	01/05
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024	10/04
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Zomedica Seeks Acquisitions	01/04
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M	01/04
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	01/04
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform	15/03
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	14/03
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences	13/03
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs	08/03
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024	06/03
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences	09/02
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET	07/02
Open Letter to Zomedica Shareholders from your Chief Executive Officer	01/02
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference	31/01
Zomedica Pharmaceuticals Reports Preliminary Q4 Revenue	17/01
Zomedica Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024	17/01
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position	11/01
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel 'X-Trode' Handpiece	05/01
Zomedica Corp. Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease	18/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zomedica Corp.

Aandelen

ZOM

CA98980M1095

Andere talen

Filters